Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1

Status

Unknown 1Completed 1Active not recruiting 1

Sponsor Class

NETWORK 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Squamous Cell Carcinoma of Head and Neck 43Head and Neck Neoplasms 35Nasopharyngeal Carcinoma 19Oropharyngeal Neoplasms 17Carcinoma, Squamous Cell 15Rectal Neoplasms 13Carcinoma, Non-Small-Cell Lung 13Prostatic Neoplasms 11Esophageal Squamous Cell Carcinoma 11Mouth Neoplasms 8Esophageal Neoplasms 8Pancreatic Neoplasms 7Laryngeal Neoplasms 7Sarcoma 6Tongue Neoplasms 5Papillomavirus Infections 5Lung Neoplasms 5Hypopharyngeal Neoplasms 5Glioblastoma 5Brain Neoplasms 5Stomatitis 4Neoplasm Metastasis 4Nasopharyngeal Neoplasms 4Carcinoma 4Breast Neoplasms 4Uterine Cervical Neoplasms 3Thyroid Carcinoma, Anaplastic 3Lymphatic Metastasis 3Gliosarcoma 3Glioma 3

Interventions

Fluorouracil 6Cisplatin 4Radiotherapy, Intensity-Modulated 3Radiotherapy 3Magnetic Resonance Spectroscopy 3Capecitabine 3dehydroftorafur 2Specimen Handling 2Mitomycin 2Cetuximab 2toripalimab 1rocakinogene sifuplasmid 1pembrolizumab 1durvalumab 1atezolizumab 1Vaccines 1VGX-3100 1Taxes 1Radiosurgery 1Radiation 1Platinum 1Paclitaxel 1Nivolumab 1Mitozytrex 1Mitomycins 1MEDI0457 1Ipilimumab 1Immunoglobulin G 1Fluorodeoxyglucose F18 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Anal Canal Carcinoma × Radiotherapy, Intensity-Modulated × Clear all
NCT04166318 2026-05-05

Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study

Eastern Cooperative Oncology Group

Phase 2 Active not recruiting
252 enrolled
Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms

NCT00423293 2019-02-27

Intensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal Cancer

Radiation Therapy Oncology Group

Phase 2 Completed
63 enrolled 15 charts
Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms

NCT00754078 2016-07-06

A Phase II Study to Assess Acute Toxicity and Quality of Life of Patients With Carcinoma of the Anal Canal Receiving Chemotherapy and Radiation Using Helical Tomotherapy

AHS Cancer Control Alberta

Phase 2 Unknown
58 enrolled
Gastrointestinal

Anal Canal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡